Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 18, 2026

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
07:18

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

p16(INK4a) Peptide mimetics identified via virtual screening.

Mark A Klein1, Kevin H Mayo, Robert A Kratzke

  • 1Research Service, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN 55417, USA. klein062@umn.edu

Bioorganic & Medicinal Chemistry Letters
|November 17, 2009
PubMed
Summary

Researchers discovered new compounds that inhibit Cdk4 and Cdk6, crucial regulators of the cell cycle. These small molecules offer a promising alternative to gene therapy for developing novel cancer treatments by targeting cell proliferation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BRCA1/2 Reversion Mutations and Cancer Therapy Resistance.

Biology·2026
Same author

Use of UDP-glucose 4-epimerase all4713 from Nostoc sp. PCC 7120 in the synthesis of galactose.

Archives of biochemistry and biophysics·2026
Same author

<i>STK11</i> as an Emerging Biomarker in Non-Small Cell Lung Cancer.

Current oncology (Toronto, Ont.)·2026
Same author

Zinc-based metal orchestrates early osteoimmune microenvironment to promote angiogenesis via macrophage-derived extracellular vesicles.

Biomaterials·2026
Same author

Structural elucidation and distribution pattern of glucuronic acid in β-glucan from Hypsizygus marmoreus using glycosidase hydrolysis.

Carbohydrate polymers·2026
Same author

NRIP1 disrupts ERα signal in Sjögren's disease via AQP5 suppression and MYC-driven salivary dysfunction.

Experimental & molecular medicine·2026

Area of Science:

  • Molecular Biology
  • Medicinal Chemistry
  • Cancer Research

Background:

  • Cell cycle progression, specifically the G1 to S phase transition, is tightly regulated by Cyclin-Dependent Kinases 4 and 6 (Cdk4/Cdk6).
  • The tumor suppressor p16(INK4a) normally inhibits Cdk4/Cdk6 activity, and its loss is implicated in cancer development.
  • Gene therapy approaches to restore p16(INK4a) activity have shown promise in reducing tumor progression but face practical limitations.

Purpose of the Study:

  • To discover novel small molecule inhibitors of Cdk4 and Cdk6.
  • To develop alternative therapeutic strategies for cancer by targeting cell cycle regulators.

Main Methods:

  • Utilized a pharmacophore model derived from the structure of a p16(INK4a)-like peptide and functional data.
  • Screened the National Cancer Institute (NCI) chemical database using the pharmacophore.

More Related Videos

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Related Experiment Videos

Last Updated: Jun 18, 2026

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
07:18

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

  • Filtered potential hits using the Qikprop program.
  • Experimentally validated the inhibitory activity of selected compounds against Cdk4 and/or Cdk6.

    • Main Results:

    • Identified four compounds demonstrating inhibitory activity against Cdk4 and/or Cdk6.
    • Achieved inhibitory concentrations (IC50) in the low micromolar (µM) range.
    • Established these compounds as potential lead structures for further drug development.

    Conclusions:

    • Discovery of novel Cdk4/Cdk6 inhibitors provides a viable alternative to gene therapy for cancer treatment.
    • These lead compounds represent a foundation for developing new cell cycle inhibitors.
    • Further optimization of these compounds could lead to effective cancer therapeutics targeting cell proliferation.